After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.
Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.
Columnist Patrick Moeschen turns to classic writers and poets to express how he is choosing hope in life with limb-girdle muscular dystrophy.
Lasting gains in swallowing ability have been reported for four people with oculopharyngeal muscular dystrophy given gene therapy in a trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results